• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection.
Abstract Helicobacter pylori infection is a major cause of morbidity and mortality worldwide. More than 50% of the global population is estimated to be infected. Differences in prevalence exist within and between countries, with higher prevalence seen among people with lower socio-economic status. Most transmission of infection occurs early in life, predominantly from person to person in the family setting. H. pylori is the cause of most peptic ulcer disease, gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma and causes symptoms in a subset of patients with functional dyspepsia. Choice of...
Source: Med J Aust - June 4, 2016 Category: Journals (General) Authors: Mitchell H, Katelaris P Tags: Med J Aust Source Type: research

Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up.
CONCLUSION: DL may have a multifactorial origin but the IELs infiltrate and HLA are strong predictive factors for CD development and a clinical diagnosis of GS. PMID: 26140001 [PubMed - in process]
Source: World Journal of Gastroenterology : WJG - June 28, 2015 Category: Gastroenterology Authors: Losurdo G, Piscitelli D, Giangaspero A, Principi M, Buffelli F, Giorgio F, Montenegro L, Sorrentino C, Amoruso A, Ierardi E, Di Leo A Tags: World J Gastroenterol Source Type: research

Does Helicobacter pylori Protect against Eosinophilic Esophagitis in Children?
ConclusionA reversed association between Hp and EoE was found in a cohort of West Virginia children. The possible explanations for these findings are discussed.
Source: Helicobacter - April 1, 2014 Category: Gastroenterology Authors: Yoram Elitsur, Baraa Alabd Alrazzak, Deborah Preston, Yulia Demetieva Tags: Original Article Source Type: research